• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Medicines Patent Pool collaborates with ViiV Healthcare

Medicines Patent Pool collaborates with ViiV Healthcare

March 1, 2013
CenterWatch Staff

The Medicines Patent Pool (MPP) has launched a collaboration with ViiV Healthcare—a joint venture of GlaxoSmithKline, Pfizer and Shionogi—to facilitate greater availability of critically needed medicines for children living with HIV.

Worldwide, 3.4 million children are living with HIV. But only 562,000 of them have access to medicines, according to the World Health Organization (WHO). Treating them with currently available drugs is challenging, as many are not adapted for use in children.

Under the collaboration, one key pediatric HIV medicine recommended by the WHO, abacavir, can be supplied in the 118 countries where 98.7% of children living with HIV reside, under a patent license.

MPP and ViiV Healthcare have agreed to negotiate more licenses to allow manufacture of low-cost versions of promising new, better adapted pediatric medicines ViiV Healthcare is currently developing. These could then be sold in the 118 countries once the medicines receive quality and safety approvals. ViiV Healthcare and MPP will work together with other stakeholders to explore the development of more pediatric medicines. MPP and ViiV Healthcare also have committed to considering solutions for countries outside the 118.

“The daunting problem of treating childhood HIV can only be solved when all stakeholders work together,” said Greg Perry, MPP’s executive director.

“The Medicines Patent Pool is a win-win-win solution—it provides an innovative new business model for the pharmaceutical industry to contribute to global health, it aids low-cost, quality medicines manufacturers by allowing them easier access to the market and, most importantly, allows people living with HIV around the world timely access to life-saving treatments,” he added.

The Medicines Patent Pool was founded by the innovative financing mechanism UNITAID, based at the World Health Organization, to lower the cost of HIV medicines through licensing of key HIV patents and to promote the development of needed formulations, such as medicines for children.

The Medicines Patent Pool is a United Nations backed, public-health driven business model that aims to lower the prices of HIV medicines and facilitate the development of better-adapted HIV medicines, founded in 2010. It works by creating a pool of relevant patents for licensing to generic manufacturers and other producers, facilitating the generic competition that brings down prices and can help stimulate innovation.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing